Abstract
Over a 3-year period, 156 of 815 patients admitted to a single institution with acute pancreatitis received total parenteral nutrition (TPN) for 2,572 patient days. Seventy had “simple” acute pancreatitis (group I) and 86 (group II) developed local complex disease (pseudocyst, abscess, or necrotic gland). In groups I and II, respectively, days without oral intake (NPO) were 13.6±1.5 (SEM) and 24.0±2.1 (p<0.005), hospital days were 19.8±1.7 and 35.8±3.2 (p<0.005), and duration of TPN was 10.9 ±1.0 and 21.0±2.3 days (p<0.005). Thirty-three patients in group I and 53 in group II required exogenous insulin. Alteration of standard formulas was necessary in 87 patients, but cessation of therapy was necessary in only one instance. Twenty catheters were removed for suspected sepsis with only 3 confirmed cases. Fat-based formulas were well tolerated in 15% of patients. During TPN, body weight rose from 95.0±2.4% to 97.4±4.3% of ideal in group I and remained at 90.5±1.8% in group II. Albumin rose from 3.36±0.10 to 3.50±0.08 g/dl in group I and from 3.01±0.07 to 3.35±0.07 g/dl in group II. The entire cohort differed from 10 randomly chosen patients who did not receive TPN in terms of days NPO (2.8±0.3) and hospital days (5.5±0.6). Variables associated with prolongation of hospital stay and time NPO were number of prognostic criteria, local complex disease, and underlying chronic pancreatitis only in select groups. We conclude that during acute pancreatitis, TPN can be administered safely but with careful monitoring and we recommend early aggressive therapy in the subgroups noted above and when underlying malnutrition exists. In the borderline patient, TPN may be administered by peripheral vein until the severity of disease is manifest.
Résumé
Pendant une période de 3 ans, 156 des 815 patients admis pour pancréatite aiguë ont reçu une alimentation parentérale totale (APT), soit en tout 2,572 jours patient. Soixante dix patients (groupe I) avaient une pancréatite simple et 86 (groupe II) avaient aussi une maladie locale complexe (pseudokyste, abcès ou nécrose du pancréas). La durée du jeûne était respectivement de 13.6±1.5 (ET) et de 24.0±2.1 (p<0.005), la durée moyenne de séjour était respectivement de 19.8±1.7 et de 35.8 ±3.2 (p<0.005) alors que la durée d'APT était respectivement de 10.9±1.0 et de 21.0±2.3 jours (p<0.005). Trente-trois patients dans le groupe I et 53 dans le groupe II avaient besoin d'insuline exogène. Un changement dans la formule standard a été nécessaire chez 87 patients mais l'APT n'a du être arrêté complètement que chez un patient seul. Vingt cathéters ont été enlevés avec suspicion de sepsis, confirmée cependant dans 3 cas seulement. Les compositions à base de lipides ont été bien tolérées chez 15% des patients. Pendant l'APT, le poids du corps s'est élevé de 95.0±2.4% à 97.4±4.3% du poids idéal chez les patients du groupe I et est resté à 90.5±1.8% chez ceux du groupe II. L'albumine s'est élevée de 3.36±0.10 à 3.50 ±0.08 g/dl dans le groupe I et de 3.01±0.07 à 3.35±0.07 g/dl dans le groupe II. La durée du jeûne (2.8±0.3) et la durée moyenne de séjour (5.5±0.6) de l'ensemble des patients différaient de ces mêmes données chez 10 autres patients choisis au hasard. Les facteurs associés avec un séjour hospitalier prolongé et sans alimentation orale étaient le nombre de critères pronostiques, l'existence de complications locales, et de pancréatite chronique sous-jacente chez certains patients. Nous concluons que pendant la pancréatite aiguë, l'APT peut être administrée sans danger sous contrôle permanent et nous conseillons un traitement agressif et précoce dans le sous groupe mentionné plus haut ou quand existe un état de nutrition déficient. Chez le patient limite, on peut se contenter d'APT par une veine périphérique tant que des signes de gravité ne se manifestent pas.
Resumen
En el curso de un período de 3 años, 156 de 815 pacientes hospitalizados en una sola institución por pancreatitis aguda recibieron nutrición parenteral total (NPT) durante 2,572 paciente-días. Setenta presentaban pancreatitis aguda “simple” (grupo I) y 86 (grupo II) desarrollaron enfermedad local complicada (pseudoquiste, absceso, o necrosis de la glándula). Las siguientes fueron las características de los grupos I y II, respectivamente: días sin ingesta oral (NPO) 13.6±1.5 (SEM) y 24.0±2.1 (p<0.005), días de hospitalización: 19.8±1.7 y 35.8±3.2 (p<0.005), y duración de la NPT: 10.9±1.0 y 21.0 ±2.3 días (p<0.005). Trienta y tres pacientes en el grupo I y 53 en el grupo II requirieron insulina exógena. Se requirió alterar la fórmula estándar en 87 pacientes, pero sólo fue necesario cesar la terapia en un caso. Veinte catéteres fueron retirados por sospecha de sepsis, pero sólo en 3 se confirmó. Las fórmulas a base de grasa fueron bien toleradas en 15% de los pacientes. En el curso de la NPT el peso corporal ascendió de 95.0±2.4% a 97.4±4.3% del peso ideal en el grupo I y se mantuvo a un 90.5±1.8% en el grupo II. La albúmina ascendió de 3.36±0.10 a 3.50±0.8 g/dl en el grupo I y de 3.01±0.07 a 3.35±0.07 g/dl en el grupo II. Toda la cohorte se diferenció de un grupo de 10 pacientes escogidos al azar que no recibieron NPT en términos del número de días NPO (2.8±0.3) y de días de hospitalización (5.5±0.6). Las variables que aparecieron asociadas con prolongación de la hospitalización y el tiempo NPO fueron el número de criterios de pronóstico, la enfermedad complicada, y la presencia de pancreatitis crónica subyacente sólo en grupos seleccionados. Nuestra conclusión es que en el curso de la pancreatitis aguda, la NPT puede ser administrada con seguridad pero bajo monitoría cuidadosa, y recomendamos terapia agresiva precoz en los subgrupos anotados anteriormente y cuando exista mal nutrición concomitante. En el paciente limitrofe se puede administrar la NPT por vía periférica hasta cuando la gravedad de la enfermedad se haga manifiesta.
Similar content being viewed by others
References
Frey, C.F.: Hemorrhagic pancreatitis. Am. J. Surg.137:616, 1979
Kivilasko, E., Fraki, O., Nikki, P., Lempinen, M.: Resection of the pancreas for acute fulminant pancreatitis. Surg. Gynecol. Obstet.152:493, 1981
Ranson, J.H.C., Rifkind, K.M., Turner, J.W.: Prognostic signs and nonoperative peritoneal lavage in acute pancreatitis. Surg. Gynecol. Obstet.143:209, 1976
Lange, P., Pedersen, T.: Initial treatment of acute pancreatitis. Surg. Gynecol. Obstet.157:332, 1983
Aldrete, J.S., Jimenez, H., Halpein, N.B.: Evaluation and treatment of acute and chronic pancreatitis. A review of 380 cases. Ann. Surg.191:664, 1980
Stone, H.H., Fabian, T.C.: Peritoneal dialysis in the treatment of alcoholic pancreatitis. Surg. Gynecol. Obstet.150:878, 1980
Kauste, A., Hockerstedt, K., Ahohen, J., Tervaskari, H.: Peritoneal lavage as a primary treatment in acute fulminant pancreatitis. Surg. Gynecol. Obstet.156:458, 1983
Kivilaakso, E., Lempinen, M., Makelainen, A., Nikki, P., Schroder, T.: Pancreatic resection versus peritoneal lavage for acute fulminant pancreatitis. Ann. Surg.199:426, 1984
Ettien, J.T., Webster, P.D.: The management of acute pancreatitis. Adv. Intern. Med.25:169, 1980
Myren, J.: Acute pancreatitis; Pathogenetic factors as a basis for treatment. Scand. J. Gastroenterol.12:513, 1977
Regan, P.T., Malagelada, J.R., Go, V.L.W., Wolf, A.M., Di-Magno, E.P.: A prospective study of the antisecretory and therapeutic effects of cimetidine and glucagon in human acute pancreatitis. Mayo Clin. Proc.56:499, 1981
Broe, P.J., Zinner, M.S., Cameron, J.L.: A clinical trial of cimetidine in acute pancreatitis. Surg. Gynecol. Obstet.154:13, 1982
Cameron, J.L., Mehigan, D.G., Zuidema, G.D.: Evaluation of atropine in acute pancreatitis. Surg. Gynecol. Obstet.148:206, 1979
Imrie, C.W., Benjamin, I.S., Ferguson, J.C., McKay, A.J., Mackenzie, I., O'Neill, J., Blumgart, L.H.: A single-centre doubleblind trial of Trasylol therapy in primary acute pancreatitis. Br. J. Surg.65:337, 1978
Durr, H.K., Maroske, D., Zelder, O., Bode, J.C.: Glucagon therapy in acute pancreatitis. Gut19:175, 1978
Studley, J.G.N., Schenk, W.G.: Pathophysiology of acute pancreatitis. Evaluation of the effect and mode of action of steroids in experimental pancreatitis in dogs. Am. J. Surg.143:761, 1982
Kimura, T., Zuidema, G.D., Cameron, J.L.: Acute pancreatitis: Experimental evaluation of steroids, albumin and Trasylol therapy. Am. J. Surg.140:403, 1980
Broe, P.J., Cameron, J.L.: Azathioprine and acute pancreatitis: Studies with an isolated, perfused, canine pancreas. J. Surg. Res.34:159, 1983
Silberman, H., Dixon, N.P., Eisenberg, D.: The safety and efficacy of a lipid-based system of parenteral nutrition in acute pancreatitis. Am. J. Gastroenterol.77:494, 1982
Feller, J.H., Brown, R.A., Toussaint, G.P.M., Thompson, A.G.: Changing methods in the treatment of severe pancreatitis. Am. J. Surg.127:196, 1974
Goodgame, J.T., Fischer, J.E.: Parenteral nutrition in the treatment of acute pancreatitis. Ann. Surg.186:651, 1977
Grant, J.P., James, S., Grabowski, V., Trexler, K.M.: Total parenteral nutrition in pancreatic disease. Ann. Surg.200:627, 1984
Blackburn, G.L., Williams, L.F., Bristrian, B., Stone, M.S., Phillips, S., Hirsch, E., Clowes, G.H.A., Gregg, J.: New approaches to the management of severe acute pancreatitis. Am. J. Surg.131:114, 1976
Kirby, D.F., Craig, R.M.: The value of intensive nutritional support in pancreatitis. J. Parent. Enteral Nutr.9:353, 1985
Konturek, S.J., Tasler, J., Cieszkowski, M., Jaworek, J., Konturek, J.: Intravenous amino acids and fat stimulate pancreatic secretion. Am. J. Physiol.236:E678, 1979
Kelly, G.A., Nahrwold, D.L.: Pancreatic secretion in response to an elemental diet and intravenous hyperalimentation. Surg. Gynecol. Obstet.143:87, 1976
Fried, G.M., Ogden, W.D., Rhea, A., Greeley, G., Thompson, J.C.: Pancreatic protein secretion and gastrointestinal hormone release in response to parenteral amino acids and lipids in dogs. Surgery92:902, 1982
Johnson, L.R., Schanbachter, L.M., Dudrick, S.J., Copeland, E.M.: Effect of long term parenteral feeding on pancreatic secretion and serum secretin. Am. J. Physiol.233:E524, 1977
Klein, E., Shnebaum, S., Ben-Ami, G., Dreiling, D.A.: Effects of total parenteral nutrition on exocrine pancreatic secretion. Am. J. Gastroenterol.78:31, 1983
Bivins, B.A., Bell, R.M., Rapp, R.P., Toedebusch, W.H.: Pancreatic exocrine response to parenteral nutrition. J. Parent. Enteral Nutr.8:34, 1984
Traverso, L.W., Abou-Zamjam, A.M., Maxwell, D.S., Lacy, S.M., Tompkins, R.K.: The effect of total parenteral nutrition or elemental diet on pancreatic proteolytic activity and ultrastructure. J. Parent. Enteral Nutr.5:496, 1981
Sax, H.C., Warner, B.W., Talamini, M.A., Hamilton, F.N., Bell, R.H., Fischer, J.E., Bower, R.H.: Early total parenteral nutrition in acute pancreatitis: Lack of beneficial effects. Am. J. Surg.153:117, 1987
Cerra, F.B.: Pocket Manual of Surgical Nutrition, St. Louis, C.V. Mosby, 1984
Nordestgaard, A.G., Wilson, S.E., Williams, R.A.: Early computerized tomography as a predictor of outcome in acute pancreatitis. Am. J. Surg.152:127, 1986
Robert, J.B., Meyer, P., Rohner, A.: Can serum and peritoneal amylase and lipase determinations help in the early prognosis of acute pancreatitis? Ann. Surg.203:163, 1986
Das, J.B., Joshi, I.D., Philippart, A.I.: Intralipid intolerance in pancreatitis: The role of hepatic triglyceride lipase in plasma clearance of the lipid emulsion. J. Pediatr. Surg.16:1021, 1981
Kimura, T., Toung, J.K., Margolis, S., Bell, W.B., Cameron, J.L.: Respiratory failure in acute pancreatitis: The role of free fatty acids. Surgery887:509, 1980
Raasch, R.H., Hak, L.J., Benaim, V., Brower, L., Levinson, S.L., Heizer, W.D.: Effect of intravenous fat emulsion on experimental acute pancreatitis. J. Parent. Enteral Nutr.7:254, 1983
Burns, G.P., Stein, T.A.: Pancreatic enzyme secretion during intravenous fat emulsion. J. Parent. Enterai Nutr.11:60, 1987
Edelman, K., Valenzuela, J.E.: Effect of intravenous lipid on human pancreatic secretion. Gastroenterology85:1063, 1983
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Robin, A.P., Campbell, R., Palani, C.K. et al. Total parenteral nutrition during acute pancreatitis: Clinical experience with 156 Patients. World J. Surg. 14, 572–579 (1990). https://doi.org/10.1007/BF01658792
Issue Date:
DOI: https://doi.org/10.1007/BF01658792